Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Mascitelli

Showing results (191-200 of 286) with videos related to

Pageof 29
Sort By:
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 15, 2008
Fitness, fatness, and chronic kidney diseaseLuca Mascitelli, Francesca Pezzetta, Mark R Goldstein
Cleveland Clinic Journal of Medicine|June 18, 2008
Methicillin-resistant Staphylococcus aureus: a link to statin therapy?Mark R Goldstein, Luca Mascitelli, Francesca Pezzetta
JAMA|October 29, 2009
Obesity and survival among patients with pancreatic cancerMark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Angiology|December 26, 2009
Earth to JUPITER: how a potent statin may actually be detrimental for lifestyle-associated diseasesLuca Mascitelli, Mark R Goldstein, Francesca Pezzetta
Circulation|January 6, 2010
Letter by Goldstein et al regarding article, "Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromso study"Mark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Drug Safety|January 26, 2008
Statins, regulatory T cells and amyotrophic lateral sclerosisMark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Pediatric Transplantation|June 20, 2008
Statins, regulatory T cells, and pediatric graft coronary artery diseaseMark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Angiology|September 18, 2008
Questioning the life-saving role of statins in patients with critical limb ischemiaLuca Mascitelli, Francesca Pezzetta, Mark R Goldstein
Chest|February 6, 2010
Vitamin D and mortality from pulmonary fibrosisLuca Mascitelli, Francesca Pezzetta, Mark R Goldstein
Medical Hypotheses|November 10, 2009
Might the widespread use of statin drugs explain the increase in prevalence of breast carcinoma in situ?Mark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Pageof 29

Showing results (191-200 of 286) with videos related to

Sort By:
Pageof 29
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 15, 2008
Fitness, fatness, and chronic kidney diseaseLuca Mascitelli, Francesca Pezzetta, Mark R Goldstein
Cleveland Clinic Journal of Medicine|June 18, 2008
Methicillin-resistant Staphylococcus aureus: a link to statin therapy?Mark R Goldstein, Luca Mascitelli, Francesca Pezzetta
JAMA|October 29, 2009
Obesity and survival among patients with pancreatic cancerMark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Angiology|December 26, 2009
Earth to JUPITER: how a potent statin may actually be detrimental for lifestyle-associated diseasesLuca Mascitelli, Mark R Goldstein, Francesca Pezzetta
Circulation|January 6, 2010
Letter by Goldstein et al regarding article, "Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromso study"Mark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Drug Safety|January 26, 2008
Statins, regulatory T cells and amyotrophic lateral sclerosisMark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Pediatric Transplantation|June 20, 2008
Statins, regulatory T cells, and pediatric graft coronary artery diseaseMark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Angiology|September 18, 2008
Questioning the life-saving role of statins in patients with critical limb ischemiaLuca Mascitelli, Francesca Pezzetta, Mark R Goldstein
Chest|February 6, 2010
Vitamin D and mortality from pulmonary fibrosisLuca Mascitelli, Francesca Pezzetta, Mark R Goldstein
Medical Hypotheses|November 10, 2009
Might the widespread use of statin drugs explain the increase in prevalence of breast carcinoma in situ?Mark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Pageof 29